Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph K-K Li

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Microbiology|July 13, 2011
Oncolytic bluetongue viruses: promise, progress, and perspectivesJoseph K-K Li
Current Protocols in Microbiology|February 7, 2012
Bluetongue virus (BTV): propagation, quantification, and storageJoseph K K Li
Current Protocols in Microbiology|May 3, 2012
Separation and isolation of BTV dsRNA segments and viral proteinsJoseph K-K Li, I-Jen Huang, Emiko Hayama
Current Protocols in Microbiology|May 5, 2010
Human parainfluenza virus type 3 (HPIV-3): construction and rescue of an infectious, recombinant virus expressing the enhanced green fluorescent protein (EGFP)Jason P Roth, Joseph K-K Li, Dale L Barnard
Acta Oncologica (Stockholm, Sweden)|September 14, 2007
Selective in vitro cytotoxic effect of human cancer cells by bluetongue virus-10Jun Hu, Chang-Yuan Dong, Joseph K K Li, et al.
Antiviral Research|February 5, 2009
A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assaysJason P Roth, Joseph K-K Li, Donald F Smee, et al.
Virus Genes|May 21, 2013
Deletion of the D domain of the human parainfluenza virus type 3 (HPIV3) PD protein results in decreased viral RNA synthesis and beta interferon (IFN-β) expressionJason P Roth, Joseph K-K Li, John D Morrey, et al.
Antiviral Research|April 22, 2008
Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse modelDale L Barnard, Craig W Day, Kevin Bailey, et al.
Antiviral Research|November 25, 2010
Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse modelYohichi Kumaki, Jane Ennis, Ramtin Rahbar, et al.
Antiviral Research|April 20, 2006
Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirinDale L Barnard, Craig W Day, Kevin Bailey, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Microbiology|July 13, 2011
Oncolytic bluetongue viruses: promise, progress, and perspectivesJoseph K-K Li
Current Protocols in Microbiology|February 7, 2012
Bluetongue virus (BTV): propagation, quantification, and storageJoseph K K Li
Current Protocols in Microbiology|May 3, 2012
Separation and isolation of BTV dsRNA segments and viral proteinsJoseph K-K Li, I-Jen Huang, Emiko Hayama
Current Protocols in Microbiology|May 5, 2010
Human parainfluenza virus type 3 (HPIV-3): construction and rescue of an infectious, recombinant virus expressing the enhanced green fluorescent protein (EGFP)Jason P Roth, Joseph K-K Li, Dale L Barnard
Acta Oncologica (Stockholm, Sweden)|September 14, 2007
Selective in vitro cytotoxic effect of human cancer cells by bluetongue virus-10Jun Hu, Chang-Yuan Dong, Joseph K K Li, et al.
Antiviral Research|February 5, 2009
A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assaysJason P Roth, Joseph K-K Li, Donald F Smee, et al.
Virus Genes|May 21, 2013
Deletion of the D domain of the human parainfluenza virus type 3 (HPIV3) PD protein results in decreased viral RNA synthesis and beta interferon (IFN-β) expressionJason P Roth, Joseph K-K Li, John D Morrey, et al.
Antiviral Research|April 22, 2008
Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse modelDale L Barnard, Craig W Day, Kevin Bailey, et al.
Antiviral Research|November 25, 2010
Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse modelYohichi Kumaki, Jane Ennis, Ramtin Rahbar, et al.
Antiviral Research|April 20, 2006
Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirinDale L Barnard, Craig W Day, Kevin Bailey, et al.
Pageof 2